Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Broad microbial cellular components in ocular pathogens refers to the collective structural and biochemical elements of bacteria, fungi, viruses, and protozoa that are targeted by broad-spectrum antimicrobial agents in ophthalmic practice. These components include the microbial cell wall, plasma membrane, essential metabolic enzymes, and nucleic acids (Source: PubMed, PMID: 15903187). Unlike targeted antibiotics that inhibit specific proteins like DNA gyrase, agents such as povidone-iodine and chlorhexidine act through non-specific mechanisms, including the oxidation of amino acids and the disruption of lipid bilayers (Source: NIH, StatPearls). This multi-targeted approach is particularly effective for preoperative antisepsis and the treatment of complex infections like infectious keratitis or endophthalmitis where the pathogen may be unknown (Source: Cochrane Library). By causing widespread damage to the microbe physical integrity and metabolic machinery, these agents provide rapid microbicidal activity and have a low propensity for inducing resistance. However, their non-specific nature can also lead to toxicity in host ocular tissues, such as corneal epithelial damage, necessitating careful clinical application (Source: American Academy of Ophthalmology).
Non-specific oxidation of microbial proteins and nucleic acids, and disruption of cell membrane integrity (Source: PubMed, PMID: 15903187).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad microbial cellular components in ocular pathogens.